Ashish Kulkarni
- Biomedical Engineering top 5%
- Immunology top 5%
- Molecular Biology
- Oncology top 10%
- Biomaterials top 5%
- Co-authors
- Anujan RameshDipika NandiSahana KumarSuri S. IyerSiva Kumar NatarajanShiladitya SenguptaAlison A. WeissVineethkrishna Chandrasekar
- Topics
- Nanoplatforms for cancer theranostics (12 papers)Inflammasome and immune disorders (11 papers)Phagocytosis and Immune Regulation (11 papers)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Ashish Kulkarni
54 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 105
- Biomedical Engineering 702
- Immunology 696
- Molecular Biology 674
- Oncology 306
- Biomaterials 275
Countries citing papers authored by Ashish Kulkarni
This map shows the geographic impact of Ashish Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashish Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashish Kulkarni more than expected).
Fields of papers citing papers by Ashish Kulkarni
This network shows the impact of papers produced by Ashish Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashish Kulkarni. The network helps show where Ashish Kulkarni may publish in the future.
Co-authorship network of co-authors of Ashish Kulkarni
This figure shows the co-authorship network connecting the top 25 collaborators of Ashish Kulkarni. A scholar is included among the top collaborators of Ashish Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashish Kulkarni. Ashish Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 14 | |
| 4 | 10 | |
| 5 | 5 | |
| 6 | 2 | |
| 7 | 3 | |
| 8 | 11 | |
| 9 | 1 | |
| 10 | 10 | |
| 11 | 2 | |
| 12 | 10 | |
| 13 | 28 | |
| 14 | 12 | |
| 15 | 169 | |
| 16 | 54 | |
| 17 | 30 | |
| 18 | 61 | |
| 19 | 27 | |
| 20 | 20 |
About Ashish Kulkarni
Ashish Kulkarni is a scholar working on Immunology, Biomaterials and Endocrinology, having authored 56 papers that have together received 1.7k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (12 papers), Inflammasome and immune disorders (11 papers) and Phagocytosis and Immune Regulation (11 papers). The work is most often cited by research in Immunology (696 citations), Biomaterials (275 citations) and Biomedical Engineering (702 citations). Ashish Kulkarni has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Anujan Ramesh, Dipika Nandi, Sahana Kumar, Suri S. Iyer, Siva Kumar Natarajan, Shiladitya Sengupta, Alison A. Weiss, Vineethkrishna Chandrasekar, Prithvi Raj Pandey and Venkata Sabbisetti. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.